Abstract
The TRK protooncogene (NTRK1) encodes a cell-surface transmembrane tyrosine kinase (TK) acting as a receptor for nerve growth factor. Oncogenic potential in thyrocytes results from replacing the 5′ portion by regulatory parts of other genes, leading to constitutive TK expression. In Italy, human papillary thyroid carcinoma (PTC) shows a frequent activation (50%) of the TK receptor genes NTRK1 and RET. Both genes undergo oncogenic rearrangements by the same mechanism. We previously reported high frequency (6/11) of rearrangement of the RET protooncogene in Chinese PTCs. Wide differences in the frequency (0–10.9%) of the NTRK1 rearrangement in PTCs have been reported in different populations. To investigate the frequency of TRK protooncogene rearrangement in Chinese thyroid tumors, we performed reverse transcriptase polymerase chain reaction to amplify specific TRK rearrangement transcripts. We examined thyroid tumor of 40 patients, including 14 papillary carcinomas, 4 follicular carcinomas, 1 Hurthle cell carcinoma, 1 insular carcinoma, and 20 nodular goiters. NF874 NIH3T3, NF723 NIH3T3, NF861 NIH3T3, and NF881 NIH3T3 were used, as controls for TRK-T3, TRK-T2, TRK-T1, and TRK, respectively. No known TRK protooncogene rearrangements were detected among the 40 thyroid tumors in our studies. We suggest that the TK receptor NTRK1 activation seems less important than RET activation im PTCs in the Chinese population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Klein, R., Jing, S., Nanduri, V., O'Rourke, E., and Barbacid, M., (1991) Cell 65, 189–197.
Martin-Zanca, D., Barbacid, M., and Parada, L. F. (1990), Genes Dev. 4, 683–694.
Pierotti, M. A., Bongarzone, I., Borello, M., Greco, A., Pilotti, S., and Sozzi, G. (1996). Genes, Chromosomes Cancer 16, 1–14.
Greco, A., Miranda, C., Pagliardini S., Fusetti, L., Bongarzone, I., and Pierotti, M. A. (1997). Genes, Chromosomes Cancer 19, 112–123.
Butti, M. G., Bongarzone, I., Ferresi, G., Mondellini, P., Borrello, M. G., and Pierotti, M. A. (1995) Genomics 28, 15–24.
Martin-Zanca, D., Hughes, S. H., and Barbacid, M. (1986). Nature 319, 743–748.
Greco, A., Mariani, C., Miranda, C., et al. (1995). Mol. Cell. Biol. 15, 6118–6127.
Greco, A., Pierotti, M. A., Bongarzone, I., Pagliardini, S., Lanzi, C., and Della Porta, G. (1992). Oncogene 7, 237–242.
Bongarzone, I., Pierotti, M. A., Monzini, N. et al. (1989) Oncogene 4, 1457–1462.
Lee, C-H., Hsu, L.-S., Chi, C.-W., Chen, G.-D., Yang, A.-H., and Chen, J.-Y. (1998). J. Clin Endocrinol. Metab. 83, 1629–1632.
Wajjwalku, W., Nakamura, S., Hasegawa, Y., et al. (1992). Jap. J. Cancer Res. 83, 671–675.
Delvincourt, C., Patey, M., Flament, J. et al. (1996). Clin. Biochem. 29, 267–271.
Bongarzone, I., Fugazzola, L., Vigneri, P., et al. (1996). J. Clin. Endocrinol. Metab. 81, 2006–2009.
Beimfohr, C., Klugbauer, S., Dimidchick, E. P., Lengfelder, E., and Rabes, H. M. (1999). Int. J. Cancer 80, 842–847.
Pierotti, M. A., Bongarzone, I., Borrelo, M. G., et al. (1995). J. Endocrinol. Invest. 18, 130–133.
Klugbauer, S., Lengfelder, E., Demidchik, E. P., and Rabes, H. M. (1995). Oncogene, 11, 2459–2467.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuo, CS., Lin, CY., Hsu, CW. et al. Low frequency of rearrangement of TRK protooncogene in chinese thyroid tumors. Endocr 13, 341–344 (2000). https://doi.org/10.1385/ENDO:13:3:341
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:13:3:341